End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
85,800 KRW | +0.47% | +2.75% | -14.54% |
May. 10 | SK Biopharmaceuticals Turns to Profit in Q1 as Sales Jump 88% | MT |
Jan. 30 | SK Biopharmaceuticals Swings to Profit in Q4 | MT |
Sales 2024 * | 492B 357M | Sales 2025 * | 644B 468M | Capitalization | 6,688B 4.86B |
---|---|---|---|---|---|
Net income 2024 * | 36B 26.17M | Net income 2025 * | 117B 85.06M | EV / Sales 2024 * | 13.4 x |
Net cash position 2024 * | 121B 87.8M | Net cash position 2025 * | 218B 158M | EV / Sales 2025 * | 10.1 x |
P/E ratio 2024 * |
177
x | P/E ratio 2025 * |
53.4
x | Employees | 252 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 35.75% |
1 day | +1.55% | ||
1 week | +2.28% | ||
1 month | -3.28% | ||
3 months | -11.87% | ||
6 months | +0.12% | ||
Current year | -14.94% |
Managers | Title | Age | Since |
---|---|---|---|
Dong-Hoon Lee
CEO | Chief Executive Officer | 56 | 22-12-31 |
Choi Jonggil
PRN | Corporate Officer/Principal | - | 22-12-31 |
Jeong-Woo Jo
PRN | Corporate Officer/Principal | - | 17-03-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Geun-Joo Hwang
BRD | Director/Board Member | 60 | 17-03-15 |
Jeong-Woo Jo
PRN | Corporate Officer/Principal | - | 17-03-15 |
Young-Ju Bang
BRD | Director/Board Member | - | 19-08-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.83% | 2 M€ | -14.14% | ||
0.08% | 15 M€ | +16.31% | ||
0.03% | 2,867 M€ | +5.89% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-02 | 85,800 | +0.47% | 76 313 |
24-05-31 | 85,400 | +1.55% | 203,807 |
24-05-30 | 84,100 | +1.82% | 108,328 |
24-05-29 | 82,600 | -1.67% | 71,544 |
24-05-28 | 84,000 | +0.12% | 68,351 |
End-of-day quote Korea S.E., May 30, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.94% | 4.84B | |
+15.54% | 78.51B | |
+13.10% | 9B | |
+58.17% | 4.96B | |
-.--% | 3.72B | |
-26.63% | 2.19B | |
+16.75% | 2.12B | |
-37.97% | 1.94B | |
-0.50% | 1.64B | |
-6.29% | 1.49B |
- Stock Market
- Equities
- A326030 Stock